Kareo announced the launch of its Apple Watch App. This most recent innovation extends the functionality of the company’s electronic health record (EHR) to Apple Watch, streamlining care delivery and enhancing the patient experience by improving communications, reducing patient wait times and increasing practice efficiency.
Medic Vision Imaging Solutions Ltd. announced the introduction and availability of SafeCT Dose Reporting. Healthcare facilities can now, for the first time, use a single software platform to meet their low dose computed tomography (CT) imaging needs while also conforming to CT dose monitoring and reporting standards.
A microsupercapacitor designed by scientists at Rice University that may find its way into personal and even wearable electronics is getting an upgrade. The laser-induced graphene device benefits greatly when boron becomes part of the mix.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA Capital, Deerfield, Sectoral Asset Management, Ally Bridge Group and two undisclosed large-cap strategic investors.
Dassault Systèmes announced during its SIMULIA Community Conference that the first heart model from its “Living Heart Project” will be commercially available on May 29, 2015. Powered by Dassault Systèmes’ 3DEXPERIENCE platform’s realistic simulation applications, the commercial, high-fidelity, scientifically validated 3-D simulator of a four-chamber human heart is the first product of its kind. With this model, device manufacturers, researchers and medical professionals will be able to perform virtual tests and visualize the heart’s response in ways that are not possible with traditional physical testing.
A new study evaluating the Boston Scientific Lotus Valve System demonstrated an extremely low rate of paravalvular aortic regurgitation (leakage) for a transcatheter aortic replacement valve. Study data also showed a cardiovascular mortality rate of less than 2 percent at 30 days.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Privately-held company Arterial Remodeling Technologies (ART) announced CE Mark clearance for its next-generation drug-free, pure bioresorbable scaffold used to treat coronary artery disease. The CE Mark was achieved following the completion of extensive pre-clinical research — this included up to three-years of follow-up, and supportive clinical results from leading coronary angioplasty centres such as the Hôpital Européen Georges Pompidou in Paris and investigators such as Jean Fajadet, M.D., at the Clinique Pasteur in Toulouse.
At EuroPCR 2015, Mitralign presented updates on its mitral and tricuspid valve repair systems, including a presentation on six-month data on its Mitral system.
Edwards Lifesciences Corp. announced that 30-day outcomes for intermediate-risk patients treated transfemorally with the SAPIEN 3 transcatheter aortic valve demonstrated very low mortality and stroke rates, and no severe paravalvular leaks. These independently adjudicated data from centers in Europe and Canada are consistent with the outcomes recently reported in a similar study of 1,000 patients treated at 51 centers in the United States. The study was presented at EuroPCR 2015 by Alec Vahanian, M.D., chair of the cardiology department at Bichat University Hospital, Paris.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
St. Jude Medical Inc. announced preliminary results from the ILUMIEN I trial and final results from the ILUMIEN II clinical study. Taken together, the findings from both studies show that with resolution up to 10 times higher than intravascular ultrasound (IVUS), optical coherence tomography (OCT) imaging can help improve stent selection and deployment, better support clinical decision-making and improve patient outcomes.
Orlando Health recently successfully unrolled Lumedx’s physician structured reporting and image management solution across five of its campuses. The implementation was smooth and swift, user adoption is 100 percent, and the benefits are manifold.
According to a new study, small changes in quality improvement procedures enabled clinicians to use magnetic resonance imaging (MRI) scans to diagnose stroke patients before giving acute treatment, within 60 minutes of arrival. MRI scans provide detailed images but take longer to complete than computed tomography (CT) scans, which are commonly used in most centers.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The cost of bringing innovative new cardiovascular technology to the U.S. market today is staggering, numbering in the tens of millions up to $1 billion. Many in the medical device and drug industries see this as a major barrier to developing new therapies. The majority of this cost is in the preclinical animal testing stage and the human clinical trials required to gain regulatory clearance. New technologies may very soon offer a way to greatly decrease these costs. In addition, these technologies may be able to identify which drugs or device therapies will be effective in humans before spending millions in potentially dead-end research.
A study in the May issue of the International Journal of Cardiovascular Imaging examines the ability of the EchoInsight software to achieve quantitative assessment of the right ventricle (RV). The study, “Semi-automated Echocardiographic Quantification of Right Ventricular Size and Function," was published by Diego Medvedofsky, Karima Addetia, Roberto Lang, Victor Mor-Avi, et al.
Holographic Optical Technologies has made its Voxgram hologram technology available to the consumer market through its just-launched Kickstarter campaign.
May 27, 2015
